Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
BACKGROUND AIMS: Stem cell therapy (SCT) is now the up-coming therapeutic modality for treatment of type 1 diabetes mellitus (T1DM). METHODS: Our study was a prospective, open-labeled, two-armed trial for 10 T1DM patients in each arm of allogenic and auto.....